Neurogene, Inc. (NGNE)
18.62
+1.41
(+8.19%)
USD |
NASDAQ |
Feb 19, 16:00
18.64
+0.02
(+0.08%)
After-Hours: 20:00
Neurogene Market Cap : 288.42M for Feb. 19, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| CorMedix, Inc. | 557.83M |
| Verastem, Inc. | 447.40M |
| Anavex Life Sciences Corp. | 381.81M |
| Coherus Oncology, Inc. | 206.69M |
| Ocugen, Inc. | 520.44M |
Market Cap Related Metrics
| Price to Book Value | 1.086 |
| Price | 18.62 |
| Earnings Yield | -23.78% |